Currently, pathologists rely on labor-intensive microscopic examination of tumor cells using century-old staining methods that can give false readings. Emerging BioMicroNano-technologies have the potential to provide accurate, realtime, high-throughput screening of tumor cells without the need for time-consuming sample preparation. These rapid, nanooptical techniques may play an important role in advancing early detection, diagnosis, and treatment of disease. In this report, we show that laser scanning confocal microscopy can be used to identify a previously unknown property of certain cancer cells that distinguishes them, with single-cell resolution, from closely related normal cells. This property is the correlation of light scattering and the spatial organization of mitochondria. In normal liver cells, mitochondria are highly organized within the cytoplasm and highly scattering, yielding a highly correlated signal. In cancer cells, mitochondria are more chaotically organized and poorly scattering. These differences correlate with important bioenergetic disturbances that are hallmarks of many types of cancer. In addition, we review recent work that exploits the new technology of nanolaser spectroscopy using the biocavity laser to characterize the unique spectral signatures of normal and transformed cells. These optical methods represent powerful new tools that hold promise for detecting cancer at an early stage and may help to limit delays in diagnosis and treatment.
Introduction
A recent conference on BioMicroNano Technologies and Medicine (1) at Sandia National Laboratories highlighted a number of exciting developments that lie at the crossroads of medicine, optics, microfluidics, semiconductor physics, and materials science (2). These developments hold promise in our efforts to develop more rapid and accurate methods for the diagnosis of cancer. The special optical and biochemical properties of mitochondria permit them to be used as biophotonic markers for detecting cancer in single cells. Mitochondria are dynamic organelles that play a central role in cellular metabolism. A major metabolic function of mitochondria is oxidative phosphorylation, a process by which oxygen is used with respiratory substrates like pyruvate from glucose, and fatty acids to synthesize ATP.
Defects in mitochondrial function have long been suspected to contribute to the development and progression of cancer. Over 70 years ago, Otto Warburg pioneered the research on mitochondrial respiration alterations in the context of cancer and proposed a mechanism to explain how they evolve during the carcinogenic process. In his series of landmark publications, he hypothesized that a key event in carcinogenesis involved the development of an "injury" to the respiratory machinery. This injury resulted in compensatory increases in glycolytic ATP pro-duction to replace the normal, high efficiency oxidative phosphorylation as the preferred means of ATP synthesis (3, 4) . Tumor cells were found to prefer making ATP by glycolysis, even in the presence of normal amounts of oxygen -a process known as aerobic glycolysis. Warburg received the Nobel prize for his work on cellular respiration in 1931 (5) . Nearly 20 years after this seminal work, it was determined that cellular respiration occurs solely in mitochondria (6) . It is interesting to note that Warburg chose to devote a significant part of his 1931 Nobel lecture to the quantal effects of light photons of different wavelengths in stimulating cellular respiration (7) . Today, these optical properties of cellular respiration have taken on renewed significance with the discovery that they are part of the rich biophotonic signature of mitochondrial structure and metabolism (8, 9) . The differences in energy metabolism between normal and cancer cells constitute a biochemical and biophysical basis to speculate that strategies might be developed to selectively identify and kill cancer cells due to their inherently compromised respiratory state.
Mitochondrial Metabolic Defects in Cancer
Since the initial publications by Warburg over half a century ago, a number of cancer-related mitochondrial defects have been identified and described in the literature (10). The phenomenon of aerobic glycolysis results in the biochemical findings of reduced pyruvate oxidation and increased lactic acid production (11). A number of additional metabolic alterations associated with mitochondrial function have been observed in cancer cells, including increased gluconeogenesis (12), increased glutamine oxidation (13), and reduced fatty acid oxidation, altered preferences for respiratory substrates, rates of electron transport, membrane anion transport, and the capacity to accumulate and retain calcium (14). The activities of certain enzymes integral to the process of oxidative phosphorylation are known to be decreased in cancer versus normal cells. For example, the measured maximal velocity for ATPase activity in mitochondria (15) and submitochondrial particles isolated from hepatocellular carcinoma is considerably lower than that in normal liver (16, 17) . Mitochondrial cytochrome c oxidase activity in total cellular homogenate and the mitochondrial samples from cultured human carcinoma cell lines is also significantly lower than that measured in the control epithelial cell line (10). In addition, the mitochondrial membrane potential has been shown to be significantly higher in carcinoma cells than in normal epithelial cells (18). It is important to note that despite the large number of metabolic aberrations thus far identified, apparently none is common to all cancer cells, and many may be an adaptation necessary to support malignant activities (19).
The mitochondria from cancer cells also differ structurally from normal cell mitochondria. One example that may have bearing on the biophotonic properties of mitochondria described in this report relates to the lipid composition of mitochondrial membranes. Analysis of the inner membrane of various tumor mitochondria has indicated elevated levels of cholesterol, varying total phospholipid content, and changes in the amount of individual phospholipids relative to normal cells (20) .
Mitochondrial DNA Defects in Cancer
Mammalian cells typically contain 10 3 -10 4 copies of mitochondrial DNA (mtDNA). The genome is a 16.5 kb closedcircular, DNA molecule that encodes two rRNAs, 22 tRNAs, and 13 polypeptides (21). Although mtDNA represents less than 1% of total cellular DNA, its gene products are essential for normal cell function. Unlike nuclear DNA, mammalian mtDNA contains no introns, has no protective histones, and is exposed to deleterious reactive oxygen species generated by oxidative phosphorylation. In addition, mtDNA replication and repair mechanisms result in the accumulation of errors in cancer (22, 23) and with normal aging (24) (25) (26) . The accumulation of mutations in mtDNA is approximately tenfold greater than that in nuclear DNA (27) . Mutations in mtDNA have been reported in a variety of cancers, including prostate (28), ovarian (29), thyroid (30), salivary (31), kidney (32), liver (33), lung (34), colon (35), gastric (36), brain (37), bladder (38), head and neck (39), breast cancers (40), and leukemia (41).
The abundance and homoplasmic nature of mitochondria make mtDNA an attractive molecular marker of cancer (21). Indeed, mutant mtDNA in tumor cells has been reported to be 220 times as abundant as a mutated nuclear marker (42). Mutated mtDNA is readily detectable in urine, blood, and saliva samples from patients with bladder, head and neck, and lung cancers (42). Furthermore, mtDNA mutations have been used as clonal markers in hepatocellular carcinoma (43) and breast cancer (40). Thus, mtDNA mutations might also prove to be extremely useful as biomarkers for the detection of many cancers.
Biophotonic Studies of Mitochondria
In the search for causes of cancer, mitochondria are receiving more scrutiny than in previous years (21, 35, 44, 45) . Mitochondria play important roles in cellular energy metabolism, free radical generation, and apoptosis. In recent years there have been an increasing number of biophotonic experiments with mitochondria, including light scattering measurements, imaging, and spectroscopic measurements (46-53). Isolated mitochondria exist in a variety of morphologies from spheres to rod to threaded networks (8, (54) (55) (56) . Further, many imaging experiments have shown the perturbative effects of calcium gradients (55, 56), UV light (55), or apoptotic agents (56) in disrupting the normal, respiring morphology of mitochondria. Recently, they have also been shown to be the primary light scattering center in most tissues, and determine the light penetrating properties of tissues and many other photonic properties (46, 53) . This arises in part from the fact that they are nearly the same size as the wavelength of light; and light scattering is optimally sensitive to particles of this size and relative refractive index. Also, mitochondria have recently been shown to support lasing modes in a laser cavity in a sensitive detection technique called photonic nanosqueezing (57). Nanosqueezing makes it possible to study the physiology of an individual mitonchondrion in a single cell. Thus, it may be feasible to study the origin of disease arising in a single organelle We have performed a number of light scattering, imaging, and spectroscopy experiments on normal and cancer cells, described below, with the goal of creating a rapid diagnostic for detecting cancer in a single cell (46).
Mitochondrial Morphology and Distribution in Normal and Diseased Cells
The morphology of mitochondria is highly variable. In dividing cells, the organelle can switch between a fragmented morphology with many ovoid-shaped mitochondria, as often shown in most textbooks (58), and a reticulum in which the organelle is a single, many-branched structure (59). Mitochondria occur in large numbers in the liver cells and are convenient models for studying mitochondria and attendant changes arising from the effects of cancer. We have examined normal liver cells and the same cells transformed into cancer cells by carcinogens. Images of both types of cells taken by two different laser scanning confocal microscopy techniques. The first is the standard laser fluorescence using molecular probes which to label the mitochondria and reveal their size, shape, and distribution within the cell. Simultaneously with the fluorescence images, the cells were imaged with an ultra-dark field technique. In this method, only light scattered at large angles is rendered visible in the image. Because mitochondria are of the optimal size for strong light scattering at wide angles, they dominate the ultradark field image. In fact, the images reveal that more than 90% of the wide angle light scattering comes from those areas of the cell where the mitochondria are present. The correlation between light scatter and mitochondrial fluorescence was also recorded with co-localization histograms.
Light Scattering By Mitochondria In Cells
Individual mitochondria that have been isolated from mammalian cells have diameters in the range 400 to 800 nm. Isolated normal human mitochondria are typically 600 to 700 nm in diameter. Abnormal human mitochondria from muscle biopsies have diameters that are larger by some 15% (8). These observation were made in our previous measurements on normal and abnormal mitochondria using biocavity laser spectroscopy and laser scanning confocal microscopy (8). Thus, the size of normal and abnormal mitochondria are submicron but still substantially large to exhibit Mie scattering rather than Rayleigh scattering (49). This is supported by the observation that mitochondria do support lasing modes in a biocavity laser, suggesting that the scattering angle is not large enough to quench the lasing process (57).
We can ask how light scattering would differ between a mitochondrial network and a random distribution of independent mitochondria. Mitochondrial spheres would be independent, not correlated in space, and randomly distributed. We would expect a far field pattern that is representative of averaged single spherical mitochondrial scatter. That pattern would be symmetrical with angular spread related to average diameter not imposing or interfering with modes set up by other internal cell structures. In a microcavity loaded with such cells, we expect less scatter, less loss, simple mode structure, and fewer modes. In contrast a mitochondrial network has interconnections that are spatially correlated and lead to a far field scattering pattern that exhibits more structure, depending upon the periodicity or self-symmetry of the network. The small angle features would be related to largescale correlations, and the large angle features related to the thickness and optical density of tubules in network. Such scatter would also influence lasing modes that occur in a biocavity laser. It would impose its own structure on normal cell modes defined by the cell as a whole and the nucleus and would interfere with those modes resulting in mode competition. In general there would be higher scatter, more loss if not dominant mode, more complicated mode structure, and more modes in the lasing spectra.
We expect that the mitochondrial network structure is not precisely periodic but has a regularity determined by the bioenergetics. That is, thermodyamics will determine some average size of a mitochondrial thread diameter, and the respiration process will set some ratio of surface area to bulk volume, according to energy demand of the cell. This in turn will impose a filling factor of mitochondria in the optical matrix. Thus, there will be an arrangement that can roughly be described by an average size, average spacing, and filling factor.
Mitochondrial Correlation Microscopy
Normal mouse liver cells (ATCC TIB-73) and their nitrosoguanidine-transformed hepatocellular carcinoma derivative cells (ATCC TIB-76) were examined under a Zeiss laser scanning confocal microscope. The cells were probed with mitochondrial selective dyes that have long-wavelength fluorescence emission, Mitotracker Red 633 dye (M-22426) from Molecular Probes (Eugene, OR). Mitotracker Red 633 dye offers advantages of better separation of the excitation wavelength (633 nm) and emission wavelength (655 nm). The concentration of the Mitotracker dye was in the range 100-500 nM, which is the suggested concentration for staining live cells. The cells were incubated with the dye for 15 minutes, pelleted and rinsed twice in PBS.
Typical superimposed images of the fluorescence and ultradark field light scattering images are shown in Figures 1B  and 1D for both types of cells. The image data are analyzed in a colocalization plot to examine the relationship between fluorescence intensity (x axis) and the scattered light intensity (y axis) for each image pixel ( Fig. 1A and 1C ). Points in quadrant 2 of the plot (the slender vertical section defined by the white lines that corresponds to low fluorescence and high scatter intensity) have been false-colored blue in the images to render cell and nuclear membranes visible. In the normal liver cells, the mitochondria are very highly organized into a network in close proximity to the nucleus (Fig. 1B) . The fluorescence outlines the nucleus which is well defined and ovoid. The regions away from nucleus near the cell membrane are almost devoid of mitochondria. Generally, the fluorescence is very bright and texture is grainy, with large fluctuations in intensity. In the ultra dark field images, the light scattering occurs predominantly from the mitochondrial network and exhibits strong correlation with the fluorescence images. This correlation is quantified in the cell colocalization histogram ( Fig. 1A) . It exhibits a very large range of variation of fluorescence intensities corresponding to the mitochondrial signals. This large range might be related to a number of factors like high biological functionality, high spatial correlation, stimulated fluorescence, and photon localization. In regions where the mitochondria are more dilute, both signals are more monodisperse, corroborating the idea that high intensity (superlinearity) in the high density regions arises from collective phenomena. Enhancement of light intensity by collective effects in suspensions of inorganic particles has been previously discussed (60-64). A small percentage (less than 1%) of scattering occurs from other internal organelles. Significant scatter (about 10%) occurs from the cell membrane (region 2 in Fig. 1A) that is uncorrelated with mitochondrial fluorescence. The shape of the cell rendered by mem-brane scatter is often irregular, not round. Additionally there is a small fraction (less than 0.5%) of light scattering from the nuclear membrane that is also uncorrelated with the mitochondrial fluorescence.
In sharp contrast to the normal cells, the mitochondria in the transformed liver cells have a very chaotic, unorganized, and random distribution about the cytosol of the cancer cells (Fig. 1D) . The fluorescence is uniformly distributed throughout the cytosol and is dull in appearance, much less intense than that in normal cells. The outline of the nucleus, defined by the fluorescence, is more irregular in shape and frequently less ovoid. The light scattering is more uniform and highly correlated with the fluorescence. In contrast to the normal cells, the cancer cells have a very monodisperse distribution as shown in the colocalization histogram (Fig.  1C) , presumably due to lower biological functionality, ran- dom distribution, lowered spatial density of the mitochondria, and lack of coherent light scattering, or nonlinear collective processes. Also, there is significant scatter from the cell membrane (Fig. 1D) , and very small scattering from the nuclear membrane, both uncorrelated with the fluorescence. Generally, the cells are very round in shape.
Nanolaser Spectroscopy of Normal and Cancer Cells
Nanolaser spectroscopy was conducted using the biocavity laser, which was invented by one of the authors (P. L. G.). The biocavity laser uses a hybrid gallium-arsenide laser that emits in the near-infrared range, at about 830 nm. It is integrated within a microfluidic chip about the size of a dime (Fig. 2C ) and designed to flow cells one at a time through the laser. The microfluidic chip is a highly sophisticated microfabricated, nano-optical device comprising a carefully designed cavity between a semiconductor light-emitting material and an external dielectric mirror ( Figs. 2A and B) . When a cell flows through this cavity, it acts as an internal waveguide, permitting light to bounce between the mirrors, and permitting the cell to be sampled hundreds of times during its course through the chamber. The waveguiding of the rays of light reflected back through the cell establishes an image of the transverse cell modes within the semiconductor gain region ( Fig. 2A) . Because the refractive index of the cell is higher than that of the bare fluid, the spectrum is redshifted and comprises a series of spectral peaks from the cytoplasmic and nuclear modes. Peak spacing, intensity and the spectral shift are sensitively dependent upon the cell size, shape, and biochemistry (protein packing and membrane complexity), respectively. Because of the smaller size of mitochondria, fewer lasing modes are supported. This results in fewer discrete bands of laser light produced (Fig. 2B) .
The power and generality of biocavity laser spectroscopy has been shown in the analysis of peripheral blood mononuclear cells (65), sickle cell anemia (66), and single cancer cells (46). The process allows high-speed interrogation of individual cells analyzed directly from the body, without need of fluorescent probes, chemical reagents, or time-consuming specimen preparation. The current configuration of the laser is optimized for use with eukaryotic cells with sizes of 5-30 µm in diameter, but also works with mitochondria which have crosssectional diameters of 600-900 nm. been observed to become less organized, become spherical or swell, lose functionality, and generally lose structural correlation with other parts of the cell (54-57). In previous experiments with suspensions of isolated mitochondria we have used biocavity laser spectroscopy to show how mitochondrial swelling results in increased diameter, decreased molecular (e.g., protein) concentration, and decreased optical density by at least a factor of two. These changes, indicate that abnormal mitochondrial would exhibit a decrease in optical scattering just as observed in the imaging data above. Thus, mitochondria in compromised cells would exhibit less turbidity, less scatter, and be more uniform in appearance as observed in these images. These observations suggest that mitochondria scatter in a biocavity laser may serve as useful markers for detecting disease without use of molecular probes or other reagents that require more time for specimen preparation.
In separate experiments, normal and transformed liver cells were studied by biocavity laser spectroscopy. This technique is the fastest demonstrated method for characterizing a cell in near physiologic condition without staining, requiring only microseconds per cell to acquire information about cell morphology and biochemistry (46). The benefit of such ultrafast laser techniques has been proposed for realizing pathology of tumors in realtime during surgery.
Cluster plots (Fig. 3 ) of the spectral parameters described along the three axes: the lasing wavelength shift, peak lasing intensity, and the lasing linewidth. This plot reveals a distinct clustering of the spectral parameters in two of the three cluster planes associated with lasing wavelength shift and lasing linewidth. Significantly, the cancer cells (the red population in Fig. 3 ) have reduced linewidth as expected from mitochondria that exhibit less correlation and scattering of intracavity coherent light. In comparison, the spatially and optically correlated mitochondria in the normal cells (the blue population in Fig. 3 ) result in lasing linewidth that is broader by a factor of about 2. The dispersion of the linewidths for each type of cell is substantially less than the difference between the mean values, allowing the cell types to be cleanly distinguished as cancer (red) and normal (blue) populations (Fig. 3 ).
Discussion and Summary
Mitochondria are dynamic intracellular organelles that play a central role in oxidative metabolism, apoptosis, and hundreds of other metabolic functions that determine the physiologic characteristics of the cell. The recent resurgence of interest in the study of mitochondria has been fuelled in large part by the recognition that genetic and metabolic alterations in this organelle are causative or contributing factors in a variety of human diseases including cancer. Several distinct differences between the mitochondria of normal cells and cancer cells have already been observed at the genetic, molecular, biochemical and biophysical levels. Certain of these alterations in mitochondrial structure and function might prove clinically useful either as markers for the early detection of cancer or as unique molecular sites against which novel and selective chemotherapeutic agents might be targeted. Given the importance of mitochondria in the development of diseases such as cancer, diabetes, heart disease, Parkinson disease, and other disorders associated with aging, it is crucial to develop methods for detecting changes in mitochondria as a marker for early detection. We expect biophotonic techniques to play a significant role because they have the capacity for ultra high-speed detection of large numbers of organelles and cells to permit accurate assessment of the statistical variations in a large population.
Future work will address the use of multicolor molecular probes in conjuction with light scattering methods to render images of the mitochondria, cytoskeleton, nucleus, and cell membrane. With these images we will study the distribution of mitochonria in both types of cells to ascertain variations in the mitochondrial size, shape, and distribution within the cell as affected by the microtubules. We will also study changes in the nucleus size, shape, and membrane integrity and examine the relationship between the nucleus and the mitochondrial distribution. We will examine the detailed architecture of the cell on the nanometer level to determine how the architectural changes would influence the cell biophotonic properties and interaction with laser probes such as intracavity laser spectroscopy.
